◆英語タイトル:Evelo Biosciences Inc (EVLO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8173
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Evelo Biosciences Inc (Evelo Biosciences), formerly Evelo Therapeutics Inc is a clinical stage biotechnology company. It focuses on the development of novel medicines designed to act on immune cells in the gut-body network for the treatment of inflammatory diseases and cancer. The company’s pipeline monoclonal microbial product candidates include EDP1066, EDP1815, and EDP1503 which are orally delivered pharmaceutical compositions of specific strains and intended to modulate systemic immunology by acting on multiple naturally evolved biological pathways through the gut-body network. It’s monoclonal microbials are applicable for the treatment of many diseases such as psoriasis, atopic dermatitis, Rheumatoid Arthritis, crohn’s colitis; and colorectal cancer. Evelo Biosciences is headquartered in Cambridge, Massachusetts, the US.
Evelo Biosciences Inc (EVLO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evelo Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evelo Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Evelo Biosciences Raises Additional USD34 Million in Venture Financing 11
Evelo Biosciences Raises USD47.5 Million in Venture Financing 12
Evelo Biosciences Raises USD50 Million in Series B Financing 13
Evelo Biosciences Raises USD30.5 Million in Venture Financing 15
Partnerships 16
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 16
Merger 17
Epiva Biosciences Merges with Evelo Biosciences 17
Licensing Agreements 18
Evelo Biosciences Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 18
Equity Offering 20
Evelo Biosciences Raises USD85 Million in IPO of Shares 20
Evelo Biosciences Raises USD6 Million in Private Placement of Series A-1 Preferred Shares 21
Evelo Biosciences Raises USD10.5 Million in Private Placement of Series A-3 Preferred Shares 22
Evelo Biosciences Inc – Key Competitors 23
Evelo Biosciences Inc – Key Employees 24
Evelo Biosciences Inc – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
Aug 02, 2018: Evelo Biosciences Reports Second Quarter 2018 Financial Results and Recent Business Highlights 26
May 31, 2018: Evelo Biosciences Reports First Quarter 2018 Financial Results and Recent Business Highlights 28
Corporate Communications 29
Feb 08, 2018: Evelo Biosciences Announces Leadership Changes 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30
List of Tables
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evelo Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evelo Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Evelo Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Evelo Biosciences Raises Additional USD34 Million in Venture Financing 11
Evelo Biosciences Raises USD47.5 Million in Venture Financing 12
Evelo Biosciences Raises USD50 Million in Series B Financing 13
Evelo Biosciences Raises USD30.5 Million in Venture Financing 15
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 16
Epiva Biosciences Merges with Evelo Biosciences 17
Evelo Biosciences Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 18
Evelo Biosciences Raises USD85 Million in IPO of Shares 20
Evelo Biosciences Raises USD6 Million in Private Placement of Series A-1 Preferred Shares 21
Evelo Biosciences Raises USD10.5 Million in Private Placement of Series A-3 Preferred Shares 22
Evelo Biosciences Inc, Key Competitors 23
Evelo Biosciences Inc, Key Employees 24
List of Figures
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evelo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evelo Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9